PTAB Casts Doubt on Judicial Estoppel Challenge at Institution Stage of IPR but Does Not Foreclose it for Trial

Jan 10, 2020

Reading Time : 2 min

Precision Planting, LLC filed a petition for IPR against a patent owned by Deere & Co. that is directed to a machine for sowing seeds. Precision asserted four obviousness grounds that all included the combination of a U.S. patent (Koning), which is directed to a machine for planting bulbs, with a German patent (Holdt), which is directed to a machine for planting seeds.

In its Patent Owner Preliminary Response, Deere argued that Precision was taking a position that was “diametrically opposite” to one it had taken several years earlier when Precision was prosecuting its own patent application. According to Deere, Precision had sought to overcome an obviousness rejection by arguing that the examiner was improperly combining Koning with a patent directed to a machine for planting seeds (Walters) because the two patents were not in the same field. The claims were subsequently allowed by the examiner. According to Deere, Precision was judicially estopped from arguing in its petition that Koning was in the same field as Holdt, a patent in the same field as Walters.

The PTAB rejected Deere’s arguments. The PTAB first noted that Deere had failed to cite “any authority squarely holding that judicial estoppel” applies to PTAB proceedings. The PTAB then explained that even if judicial estoppel were assumed to apply, Precision had made an adequate showing to defeat its applicability at the institution stage. According to the PTAB, the arguments that Precision made during prosecution occurred under an obviousness regime that was abrogated by the Supreme Court’s KSR decision, meaning that Precision’s position in its petition was not necessarily inconsistent with its earlier position during prosecution.

Moreover, because judicial estoppel only applies when a party was successful, the PTAB explained, the record did not show that Precision had successfully persuaded the examiner that Koning was in a different field because Precision had also made claim amendments that could have been the basis for the examiner allowing the claims to issue. Although the PTAB declined to apply estoppel at the institution stage, the PTAB allowed the parties to further address the issue during the trial stage of the IPR proceeding.

Practice Tip:

Parties to a PTAB proceeding should be aware of potential challenges arising from inconsistent arguments presented not just to the PTAB, but across proceedings before the Patent Office. When faced with such challenges, parties should assess—and leverage—the impact of changed circumstances, including changes undergone by the governing caselaw.

Precision Planting, LLC v. Deere & Co., Case IPR2019-01052, Paper 19 (Jan. 7, 2020)

Share This Insight

Previous Entries

IP Newsflash

October 1, 2025

In a recent final written decision, the PTAB determined that a reference patent was not prior art, despite the petitioner’s post‑filing attempt to correct its petition. While the petitioner argued that it intended to rely on the patent application’s earlier date of publication, both the corrected petition and the expert declaration continued to reference the issued patent rather than the published application.

...

Read More

IP Newsflash

September 30, 2025

The USPTO Director recently granted a petitioner’s request for rehearing of the decision discretionarily denying institution of inter partes review, ultimately vacating the original decision, and referring the petition to the board for an institution decision.

...

Read More

IP Newsflash

September 25, 2025

In considering claims to a method of reducing cardiovascular events, the Federal Circuit held that the term a “clinically proven effective” amount did not render the claims patentable over the prior art. Specifically, the Federal Circuit held that the “clinically proven effective” amount, whether limiting or not, could not be used to distinguish the prior art because the claims also specified the exact amount of the drugs to be administered in the method. The Federal Circuit also rejected patentee’s evidence of unexpected results because that evidence was tied solely to the “clinically proven effective” limitation.

...

Read More

IP Newsflash

September 24, 2025

The Federal Circuit reversed a district court’s denial of judgment as a matter of law on non-infringement, thereby setting aside a $106 million jury verdict, after holding that prosecution history estoppel barred the patentee from asserting infringement under the doctrine of equivalents.

...

Read More

IP Newsflash

September 17, 2025

A magistrate judge in the District of Delaware issued a Report and Recommendation, that found the sole asserted claim was a “single means” claim and therefore invalid for lack of enablement. In reaching that conclusion, the magistrate judge rejected the patentee’s argument that the preamble of the claim disclosed a second element that satisfied the combination requirement of Section 112, paragraph 6 because the preamble simply recited a descriptor of the very apparatus that was the subject of the means-plus-function limitation in the body of the claim. The district court judge presiding over this case has scheduled a hearing to review the magistrate’s ruling.

...

Read More

IP Newsflash

September 9, 2025

The Federal Circuit has affirmed the PTAB’s determination that a patent challenger did not show the challenged claims were unpatentable for obviousness. The Federal Circuit concluded that substantial evidence, which included expert testimony, showed there was no motivation to combine the references.

...

Read More

IP Newsflash

August 29, 2025

In a recent order addressing four IPR proceedings, the PTAB exercised its inherent authority under 37 C.F.R. § 42.5(a) to sua sponte authorize post-hearing discovery on a potentially dispositive privity issue. The order followed a Director review decision that vacated and remanded earlier IPRs involving the same parties, patent family, and privity issue. 

...

Read More

IP Newsflash

August 29, 2025

The Patent Trial and Appeal Board denied institution of an inter partes review petition in part because it determined that a patent reference was not prior art under the common ownership exception of pre-AIA 35 U.S.C. § 103(c)(1).

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.